EOM Pharmaceuticals Holdings, Inc. (IMUC)

IMUC Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.55	1.49	0.26
Cash & Short-Term Investments	0.55	1.49	0.26
Cash Growth	4391.70%	465.28%	-
Prepaid Expenses	0.16	0.18	-
Total Current Assets	0.71	1.67	0.26
Other Long-Term Assets	-	-	0
Total Assets	0.71	1.67	0.27

Liabilities

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Accrued Expenses	0.73	0.47	0.14
Total Current Liabilities	0.73	0.47	0.14
Long-Term Debt	3.05	2.82	-
Total Liabilities	4.44	3.28	0.14

Shareholders' Equity

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	0.01	0.01	0
Additional Paid-In Capital	5.05	4.97	1.58
Retained Earnings	-8.78	-6.6	-1.45
Total Common Equity	-3.73	-1.62	0.13
Shareholders' Equity	-3.73	-1.62	0.13
Total Liabilities & Equity	0.71	1.67	0.27

Additional Metrics

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	3.05	2.82	-
Net Cash (Debt)	-2.5	-1.33	0.26
Net Cash Growth	-	-	-
Net Cash Per Share	-0.03	-0.03	0.01
Filing Date Shares Outstanding	113.27	113.27	50
Total Common Shares Outstanding	113.27	113.27	50
Working Capital	-0.02	1.2	0.13
Book Value Per Share	-0.03	-0.01	0.00
Tangible Book Value	-3.73	-1.62	0.13
Tangible Book Value Per Share	-0.03	-0.01	0.00

Data Source: S&P Global Market Intelligence Last updated: Dec 20, 2022

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 4, 2026

Data Sources Report a data error